-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-FDA Identified Several Concerns With Accepting Susceptible Minocycline Breakpoint Against S. maltophilia of 1 mcg/mL

Reuters·10/30/2026 18:33:56

Please log in to view news